Joeli A Brinkman
Overview
Explore the profile of Joeli A Brinkman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
127
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Drews-Elger K, Brinkman J, Miller P, Shah S, Harrell J, Da Silva T, et al.
Breast Cancer Res Treat
. 2014 Feb;
144(3):503-17.
PMID: 24567196
Our goal was to establish primary cultures from dissociation of breast tumors in order to provide cellular models that may better recapitulate breast cancer pathogenesis and the metastatic process. Here,...
2.
Brinkman J, El-Ashry D
J Mammary Gland Biol Neoplasia
. 2009 Mar;
14(1):67-78.
PMID: 19263197
Breast cancer is the leading cause of cancer amongst women in the westernized world. The presence or absence of ERalpha in breast cancers is an important prognostic indicator. About 30-40%...
3.
Brinkman J, Hughes S, Stone P, Caffrey A, Muderspach L, Roman L, et al.
Dis Markers
. 2007 Jul;
23(4):337-52.
PMID: 17627067
Cervical Cancer is the second leading cause of cancer-related deaths in women worldwide and is associated with Human Papillomavirus (HPV) infection, creating a unique opportunity to treat cervical cancer through...
4.
Brinkman J, Xu X, Kast W
Vaccine
. 2007 Jan;
25(17):3437-44.
PMID: 17241713
A majority of cervical cancers are associated with Human Papillomavirus (HPV)-16. A DNA vaccine (E7IR) was designed for prophylactic and therapeutic treatment of HPV-16+ tumors containing two repeats of the...
5.
Chaturvedi A, Brinkman J, Gaffga A, Dumestre J, Clark R, Braly P, et al.
J Gen Virol
. 2004 Apr;
85(Pt 5):1237-1241.
PMID: 15105540
The prevalence of human papillomavirus type 16 E6 variant lineages was characterized in a cross-sectional study of 24 human immunodeficiency virus type 1 (HIV)-positive and 33 HIV-negative women in New...
6.
Brinkman J, Rahmani M, Jones W, Chaturvedi A, Hagensee M
J Clin Virol
. 2004 Mar;
29(4):230-40.
PMID: 15018850
Background: Human papillomavirus (HPV) causes cervical cancer. Current screening requires a yearly pelvic exam and Pap smear. However, these procedures are impractical for screening all women at risk for disease....
7.
Brinkman J, Fausch S, Weber J, Kast W
Expert Opin Biol Ther
. 2004 Mar;
4(2):181-98.
PMID: 14998777
One approach in the immunotherapy of cancer patients involves vaccination with peptides derived from tumour-associated antigens specifically designed to associate with T cells in the context of major histocompatibility complex...
8.
Brinkman J, Jones W, Gaffga A, Sanders J, Chaturvedi A, Slavinsky III J, et al.
J Clin Microbiol
. 2002 Aug;
40(9):3155-61.
PMID: 12202546
Human immunodeficiency virus (HIV)-positive women may represent one of the fastest-growing populations at risk for acquiring cervical cancer and thus require frequent screening. The purpose of the present studies was...